UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
P P- P0 P1 P2 P3 P4 P5 P6 P7 P8 P9 PA PB PC PD PE PF PG PH PI PK PL PM PN PO PP PQ PR PS PT PU PV PW PX PY
PYE PYL PYO PYR
selected terms: 107 page 1 of 2

1. 1-Pyrrolidineethanamine, beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, Monohydrochloride
[The hydrochloride salt form of bepridil, a calcium antagonist and class IV anti-arrhythmic agent. Bepridil hydrochloride blocks calcium entry through membranous calcium channels of coronary and peripheral vascular smooth muscle, thereby dilating coronary arteries and peripheral arterioles. This increases oxygen delivery and reduces oxygen requirements. This drug is used to treat chronic stable and variant angina pectoris. ( NCI )] (UMLS (NCI) C0770909) Bepridil Hydrochloride;
BEPRIDIL HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =Bepridil;
=BEPRIDIL HYDROCHLORIDE 300 MG;
BEPRIDIL HYDROCHLORIDE 200 MG
51. Pyrazine Diazohydroxide
[An anticancer drug. ( NCI )] (UMLS (NCI) C0072657) =Organic Chemical; Pharmacologic Substance
2. 2-(2-Pyridyl)ethylidine-1,1-bisphosphonate
[A synthetic pyridinyl bisphosphonate with anti-resorptive activity. Although the exact mechanism of action has yet to be fully elucidated, piridronic acid likely binds to hydroxyapatite crystals in the bone matrix and inhibits farnesyl pyrophosphate synthase, an enzyme that plays an important role in the mevalonate pathway. This inhibits the formation of isoprenoid metabolites that are substrates for protein prenylation. This prevents farnesylation and geranylgeranylation of proteins essential for osteoclast function, leading to the induction of apoptosis and eventually, osteoclast-cell death. By preventing osteoclast-mediated bone resorption, piridronic acid decreases bone turnover and stabilizes the bone matrix. ( NCI )] (UMLS (NCI) C0045686) =Organophosphorus Compound; Pharmacologic Substance ;
52. Pyrazole Compound
[A class of heterocyclic organic compounds characterized by a ring structure composed of three carbon atoms and two nitrogen atoms in adjacent positions. Derivatives of pyrazole exhibit a variety of pharmacological properties, including anti-inflammatory, anti-psychotic, antibiotic and antineoplastic. ( NCI )] (UMLS (NCI) C0034242) =Organic Chemical; Pharmacologic Substance ;
=Heterocyclic Compounds, 1-Ring;
=antipyrine;
Indazoles;
PHENYLBUTAZONE;
1H-Pyrazole, 4-methyl-;
3. 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-
[A phenylbutazone derivative with uricosuric and antithrombotic properties. Sulfinpyrazone competitively inhibits reabsorption of urate at the proximal renal tubule in the kidney. This agent acts on the organic anion transport exchanger, thereby increasing uric acid excretion and decreasing serum uric acid levels resulting in the prevention of urate deposition. Sulfinpyrazone also blocks tubular excretion of various acidic drugs, resulting in increased serum concentration of the drugs. In addition, sulfinpyrazone and its active metabolite inhibit the synthesis of thromboxane A2, by competitively inhibiting the activity of cyclooxygenase, thereby preventing platelet aggregation through restoration of platelet survival time to normal, and decreasing platelet adhesiveness to subendothelial cells. ( NCI )] (UMLS (NCI) C0038742) =Organic Chemical; Pharmacologic Substance ;
=[MS400] ANTIGOUT AGENTS;
PHENYLBUTAZONE =SULFINPYRAZONE 100 MG;
SULFINPYRAZONE 200 MG
53. pyrazolidinedione
[ ] (UMLS (CSP) C0599258) =Organic Chemical ;
4. 3,5-Pyridinedicarboxylic Acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, Methyl 1-methylethyl Ester
[A dihydropyridine calcium channel blockers with antihypertensive and vasodilator activity. Isradipine blocks the calcium entry through the calcium ion channels of coronary and peripheral vascular smooth muscle, thereby dilating coronary arteries and peripheral arterioles. This increases oxygen delivery due to an increased blood flow and reduces oxygen requirements due to decrease in total peripheral resistance. (NCI05) ( NCI )] (UMLS (NCI) C0071304) =Organic Chemical; Pharmacologic Substance ;
=[CV200] CALCIUM CHANNEL BLOCKERS;
Dihydropyridines;
[CV250] ANTIANGINALS;
=ISRADIPINE 2.5 MG;
ISRADIPINE 5 MG;
ISRADIPINE 10 MG
54. Pyrazoloacridine
[Pyrazoloacridine is an acridine derivative topoisomerase I/II inhibitor currently undergoing clinical evaluation. It binds to DNA by intercalation. In preclinical testing has shown selectivity for solid tumor cell lines, activity in hypoxic, noncycling, and multidrug-resistant cell lines, and synergy with cisplatin. ( NCI )] (UMLS (NCI) C0280970) =Organic Chemical; Pharmacologic Substance
5. 3-Pyridinecarboxamide
[B complex vitamin used in the prophylaxis and treatment of pellagra; functions as a component of the coenzyme NAD (Nicotinamide-Adenine Dinucleotide). ( CSP )] (UMLS (NCI) C0028027) =Organic Chemical; Pharmacologic Substance; Vitamin =[VT103] NICOTINIC ACID;
3-Pyridinecarboxamide;
Nicotinic Acids;
[VT100] VITAMIN B;
TO BE DELETED INGREDIENT PREPARATIONS;
Unclassified Ingredient Preparations =3-Pyridinecarboxamide;
NICOTINAMIDE HYDRIODIDE;
NIACIN (AS NIACINAMIDE) 28 MG/L;
NIACIN (AS NIACINAMIDE) 3.33 MG;
NIACIN (AS NIACINAMIDE) 30 MG;
CITROTEIN POWDER (ORANGE);
MERITENE POWDER (CHOCOLATE);
MERITENE POWDER (MILK More…
55. pyrazolopyrimidine
[ ] (UMLS (CSP) C0597328) =Organic Chemical ;
=Pyrimidine;
=1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one;
6. Pyelitis
[Inflammation of the KIDNEY PELVIS and KIDNEY CALICES where urine is collected before discharge, but does not involve the renal parenchyma (the NEPHRONS) where urine is processed. ( MSH )] (UMLS (NCI) C0034183) =Disease or Syndrome ;
=Kidney Disease;
=pyelonephritis;
56. pyrene
[polycyclic hydrocarbon, C16H10. ( CSP )] (UMLS (CSP) C0034243) =Organic Chemical; Hazardous or Poisonous Substance ;
=carbopolycyclic compound;
=benzopyrene
7. Pyelitis or pyelonephritis in diseases classified elsewhere
(UMLS (ICD9CM) C0156256) =Disease or Syndrome ;
57. PYRENE
[A parent class of polycyclic aromatic hydrocarbons containing four fused rings. (IUPAC 1998) ( NCI )] (UMLS (NCI) C0072667) =Organic Chemical ;
8. pyelography
[ ] (UMLS (CSP) C0034185) =Diagnostic Procedure ;
58. pyrethroid
[active insecticidal constituents of pyrethrum (Chrysanthemum cinerariifolum) flowers. ( CSP )] (UMLS (CSP) C0597329) =Organic Chemical; Hazardous or Poisonous Substance =plant insecticide;
9. pyelonephritis
[inflammation of the kidney and its pelvis due to infection. ( CSP )] (UMLS (CSP) C0034186) =Disease or Syndrome ;
=INFECTION OF KIDNEY NOS;
nephritis;
Interstitial Nephritis;
Pyelitis =Pyelonephritis, Xanthogranulomatous
59. PYREXIA IN LABOR-ANTEPAR
[ ] (UMLS (ICD9CM) C0157178) =Disease or Syndrome
10. Pyelonephritis/pyelitis acute
(UMLS (ICPC) C0497417) (Pyelonephritis/pyelitis acute; PIELONEFRITIA/PIELITIS,ZORROTZA; Pyelonefrit/akut pyelit; Acute pyelonephritis/pyelitis; AKUUTTI PYELONEFRIITTI/PYELIITTI; Pyelonephrite/pyelite aigue; akute Pyelonephritis/Pyelitis; pyelitis/pyelonefritis xarifa; pyelonephritis/pyelitis acuta; Pielonefrite/pielite acuta; NYREBEKKENBETENN/PYELITT AKUTT; Pielonefrite/pielite aguda; Pielitis/pielonefritis, aguda; PYELONEFRIT/PYELIT AKUT) =Disease or Syndrome =Urologic; Diagnosis/Diseases Component
60. PYREXIA IN LABOR-DELIVER
[ ] (UMLS (ICD9CM) C0157177) =Disease or Syndrome
11. PYELOSCOPY
[ ] (UMLS (ICD9CM) C0176990) =Diagnostic Procedure
61. PYREXIA IN LABOR-UNSPEC
[ ] (UMLS (ICD9CM) C0157176) =Disease or Syndrome
12. PYELOSTOMY
(UMLS (ICD9CM) C0194121) =Therapeutic or Preventive Procedure
62. Pyrexia of unknown origin during the puerperium
[ ] (UMLS (ICD9CM) C0157536) =Disease or Syndrome
13. PYELOTOMY
(UMLS (ICD9CM) C0194063) =Therapeutic or Preventive Procedure
63. pyridazine
[ ] (UMLS (CSP) C0072677) =Organic Chemical ;
14. Pyelotomy and pyelostomy
[ ] (UMLS (ICD9CM) C0176986) =Therapeutic or Preventive Procedure
64. pyridine
[6-membered aromatic ring structure with one nitrogen heteroatom. ( CSP )] (UMLS (CSP) C0034255) =Organic Chemical =Heterocyclic Compounds, 1-Ring;
nitrogenous heterocyclic compound =methylphenyltetrahydropyridine;
aminopyridine;
chlorphenamine;
disopyramide;
indolizine;
1-Propanone, 2-methyl-1,2-di-3-pyridinyl-;
(-)-Nicotine;
paraquat;
piperidine;
pyridinone;
PYRIDOSTIGMINE;
VIT B6;
DHP;
pyridine carboxylate;
aminopyridine;
carboline;
Dihydropyridines;
disopyramide;
DOXYLAMINE;
Isonicotinic Acids;
1-Propanone, 2-methyl-1,2-di-3-pyridinyl-;
(-)-Nicotine;
Nicotinic Acids;
NICOTINYL ALCOHOL;
PHENIRAMINE;
Picoline;
Pyridinium Compounds;
pyridinone;
TRIPROLIDINE;
Benzeneacetamide, N-ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)-;
CARBINOXAMINE;
phenindamine;
2-Mercaptopyridine 1-oxide Zinc Salt;
ZOLPIDEM;
NEVIRAPINE;
IDV;
CERIVASTATIN
15. PYELOURETERITIS CYSTICA
(UMLS (ICD9CM) C0156254) =Disease or Syndrome ;
65. pyridine carboxylate
[ ] (UMLS (CSP) C0597330) =Organic Chemical ;
=pyridine;
=[VT103] NICOTINIC ACID;
NICARDIPINE;
NIFEDIPINE;
NIMO;
nitrendipine;
16. Pyloric Gland
(UMLS (NCI) C0227239) =Body Part, Organ, or Organ Component
66. pyridine nucleoside
[ ] (UMLS (CSP) C0598997) =Nucleic Acid, Nucleoside, or Nucleotide ;
17. Pyloric Orifice
(UMLS (NCI) C0227237) =Body Space or Junction
67. pyridine nucleotide
[ ] (UMLS (CSP) C0597331) =Nucleic Acid, Nucleoside, or Nucleotide ;
=nucleotide;
=nicotinamide ribotide;
18. pyloric region
[distal aperture of the stomach surrounded by a strong band of circular muscle through which the stomach contents are emptied into the duodenum; includes the pyloric part of the stomach, and the pyloric antrum, canal, opening, and sphincter. ( CSP )] (UMLS (CSP) C0684202) =Body Location or Region ;
=Gastrointestinal Tract, Stomach;
68. pyridinone
[Pyridine derivatives with one or more keto groups on the ring. ( MSH )] (UMLS (CSP) C0034260) =Organic Chemical =pyridine;
=Iodopyridones;
TRAZODONE;
CICLOPIROX
19. pyloric region disorder
[ ] (UMLS (CSP) C0597327) =Disease or Syndrome ;
69. Pyridoglutethimide
[An orally active aminoglutethimide derivative with potential antineoplastic activity. Rogletimide reversibly inhibits the activity of aromatase, a cytochrome P450 family enzyme found in many tissues and the key enzyme in the oxidative aromatization process of androgens to estrogens. In estrogen-dependent cancers, the inhibition of aromatase by this agent leads to a reduction in the synthesis of estrogen, thereby inhibiting estrogen-mediated signal transduction and consequently reducing tumor cell growth. In addition, rogletimide also inhibits enzymes that catalyzing conversion of cholesterol to corticosteroids. ( NCI )] (UMLS (NCI) C0164550) =Organic Chemical; Pharmacologic Substance ;
20. pyloric sphincter
[ ] (UMLS (CSP) C0227238) =Body Part, Organ, or Organ Component
70. pyridoindole
[ ] (UMLS (CSP) C0597332) =Organic Chemical ;
=indole;
21. pyloric stenosis
[Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants. ( MSH )] (UMLS (CSP) C0034194) =Finding ;
=Gastric Outlet Obstruction;
71. pyridoxal
[The 4-carboxyaldehyde form of VITAMIN B 6 which is converted to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. ( MSH )] (UMLS (CSP) C0034263) =Organic Chemical; Vitamin ;
=Picoline;
[VT100] VITAMIN B =pyridoxal phosphate
22. PYLOROMYOTOMY
[ ] (UMLS (ICD9CM) C0192407) =Therapeutic or Preventive Procedure
72. pyridoxal analog
[ ] (UMLS (CSP) C0599624) =Organic Chemical; Pharmacologic Substance; Vitamin
23. pyloroplasty
[ ] (UMLS (CSP) C0192489) =Therapeutic or Preventive Procedure
73. pyridoxal kinase
[An enzyme that catalyzes reversibly the phosphorylation of pyridoxal in the presence of ATP with the formation of pyridoxal 5-phosphate and ADP. Pyridoxine, pyridoxamine and various derivatives can also act as acceptors. EC 2.7.1.35. ( MSH )] (UMLS (CSP) C0034265) =Amino Acid, Peptide, or Protein; Enzyme ;
24. PYLOROSPASM
(UMLS (ICD9CM) C0152163) =Disease or Syndrome
74. pyridoxal phosphate
[This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE). ( MSH )] (UMLS (CSP) C0034266) =Organic Chemical; Pharmacologic Substance; Vitamin =coenzyme;
pyridoxal;
cofactor;
=N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
25. Pylorus
[The region of the STOMACH at the junction with the DUODENUM. It is marked by the thickening of circular muscle layers forming the pyloric sphincter to control the opening and closure of the lumen. ( MSH )] (UMLS (NCI) C0034196) =Body Part, Organ, or Organ Component ;
75. pyridoxamine
[The 4-aminomethyl form of VITAMIN B 6. During transamination of amino acids, PYRIDOXAL PHOSPHATE is transiently converted into pyridoxamine phosphate. ( MSH )] (UMLS (CSP) C0034268) =Organic Chemical; Vitamin ;
26. pyoderma
[Any purulent skin disease (Dorland, 27th ed). ( MSH )] (UMLS (CSP) C0034212) =Disease or Syndrome ;
=Cutaneous Disorder;
=Ecthyma;
Pyoderma gangrenosum;
76. pyriform area
[ ] (UMLS (CSP) C0228286) =Body Location or Region
27. Pyoderma gangrenosum
[An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown. ( MSH )] (UMLS (ICD9CM) C0085652) =Disease or Syndrome =pyoderma;
skin ulcer;
Skin Diseases, Vascular;
77. Pyriform Sinus
(UMLS (NCI) C0227170) =Body Space or Junction
28. PYOGEN ARTHRITIS NEC
[ ] (UMLS (ICD9CM) C0157757) =Disease or Syndrome
78. PYRIMETHAMINE
[A synthetic derivative of ethyl-pyrimidine with potent antimalarial properties. Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. This agent is often used in combination with other antimalarials for the treatment of uncomplicated falciparum malaria. (NCI04) ( NCI )] (UMLS (NCI) C0034283) =Organic Chemical; Pharmacologic Substance =Antimalarials;
Pyrimidine =PYRIMETHAMINE 25 MG
29. PYOGEN ARTHRITIS-ANKLE
[ ] (UMLS (ICD9CM) C0157756) =Disease or Syndrome
79. Pyrimethamine Sulfadoxine
[A combination product containing pyrimethamine and sulfadoxine. Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. Sulfadoxine competitively antagonizes paraaminobenzoic acid (PABA), resulting in disruption of folic acid synthesis and ultimately DNA synthesis. Sulfadoxine acts synergistically with pyrimethamine. (NCI04) ( NCI )] (UMLS (NCI) C0700599) =Organic Chemical; Pharmacologic Substance ;
30. PYOGEN ARTHRITIS-FOREARM
[ ] (UMLS (ICD9CM) C0263683) =Disease or Syndrome
80. Pyrimidine
[6-membered aromatic ring structure with 2 meta nitrogen heteroatoms. ( CSP )] (UMLS (NCI) C0034289) =Organic Chemical ;
=Heterocyclic Compounds, 1-Ring;
diazine =alloxan;
barbiturate;
PYRIMETHAMINE;
2,4-dihydroxy-5-methylpyrimidine;
2, 4-Dioxopyrimidine;
orotate;
aminopyrimidine;
pyrazolopyrimidine;
buspirone;
2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol;
2,3-Dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine;
PYRANTEL;
PYRIMETHAMINE;
Pyrimidinones;
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine;
OXYPHENCYCLIMINE;
Zaleplon
31. PYOGEN ARTHRITIS-HAND
[ ] (UMLS (ICD9CM) C0263684) =Disease or Syndrome
81. pyrimidine analog
[synthetic or natural chemical compounds which resemble pyrimidine in structure and/or function. ( CSP )] (UMLS (CSP) C0280039) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=nucleobase analog;
=4-Amino-5-fluoro-2(1H)-pyrimidinone;
cytosine analog;
fluoropyrimidine;
thiopyrimidine;
uracil analog
32. PYOGEN ARTHRITIS-L/LEG
[ ] (UMLS (ICD9CM) C0263687) =Disease or Syndrome
82. pyrimidine deoxyriboside
[ ] (UMLS (CSP) C0599263) =Nucleic Acid, Nucleoside, or Nucleotide ;
33. PYOGEN ARTHRITIS-MULT
[ ] (UMLS (ICD9CM) C0263690) =Disease or Syndrome
83. pyrimidine metabolism
[ ] (UMLS (CSP) C0920641) Pyrimidine Metabolism Pathway =Molecular Function ;
34. PYOGEN ARTHRITIS-PELVIS
[ ] (UMLS (ICD9CM) C0157754) =Disease or Syndrome
84. pyrimidine metabolism disorder
[ ] (UMLS (CSP) C0268127) =Disease or Syndrome ;
35. PYOGEN ARTHRITIS-SHLDER
[ ] (UMLS (ICD9CM) C0263681) =Disease or Syndrome
85. pyrimidine nucleoside
[pyrimidine bases attached to a ribose or deoxyribose. ( CSP )] (UMLS (CSP) C0034287) =Nucleic Acid, Nucleoside, or Nucleotide ;
=nucleoside;
=cytosine nucleoside;
uracil nucleoside;
cytidine;
formycin;
dT;
UR;
36. PYOGEN ARTHRITIS-UNSPEC
[ ] (UMLS (ICD9CM) C0343175) =Disease or Syndrome
86. pyrimidine nucleotide
[one of the monomeric units from which DNA or RNA polymers are constructed, consisting of a pyrimidine base, a pentose sugar, and a phosphate group. ( CSP )] (UMLS (CSP) C0034288) =Nucleic Acid, Nucleoside, or Nucleotide ;
=nucleotide;
=cytosine nucleotide;
thymidine monophosphate;
uracil nucleotide
37. PYOGEN ARTHRITIS-UP/ARM
[ ] (UMLS (ICD9CM) C0263682) =Disease or Syndrome
87. pyrimidine phosphorylase
[An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. EC 2.4.2.3. ( MSH )] (UMLS (CSP) C0042006) =Amino Acid, Peptide, or Protein; Enzyme ;
=pentosyltransferase;
38. Pyopen
(UMLS (NCI) C0034217) =Organic Chemical; Antibiotic
88. pyrindole
[ ] (UMLS (CSP) C0598688) =Organic Chemical
39. pyorrhea
[ ] (UMLS (CSP) C0553735) =Disease or Syndrome
89. Pyrithione
(UMLS (NCI) C0072735) =Organic Chemical; Pharmacologic Substance =[DE400] SOAPS/SHAMPOOS/SOAP-FREE CLEANSERS;
=2-Mercaptopyridine 1-oxide Zinc Salt
40. Pyosalpinx
(UMLS (NCI) C0034220) =Disease or Syndrome ;
90. pyrogen
[substance capable of increasing body temperature; may be of microbial origin, often polysaccharides and may contaminate distilled water. ( CSP )] (UMLS (CSP) C0034304) =Carbohydrate; Biologically Active Substance =Drug;
=Bacterial Pyrogen
41. Pyoureter
(UMLS (NCI) C0034223) =Disease or Syndrome ;
91. Pyroglyphidae
[Family of house dust mites, in the superfamily Analgoidea, order Astigmata. They include the genera Dermatophagoides and Euroglyphus. ( MSH )] (UMLS (CSP) C0998367) =Invertebrate
42. Pyramid Lake Paiute Tribe of the Pyramid Lake Rese
(UMLS (HL7) C1554446) =Population Group =NativeEntityContiguous;
92. pyrone
[Keto-pyrans. ( MSH )] (UMLS (CSP) C0034314) =Organic Chemical ;
=pyran;
cyclic ketone =2H-1-Benzopyran-2-one;
ethyl maltol;
43. Pyramid of Ferrein
[Conical structures of the cortical portion of the kidney. The apices of these structures reach the periphery of the kidney, and the bases are applied to the medullary portion. ( NCI )] (UMLS (NCI) C1185585) =Body Part, Organ, or Organ Component
93. pyrophosphatase
[nonEC; catalyses the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. ( CSP )] (UMLS (CSP) C0034318) =Amino Acid, Peptide, or Protein; Enzyme =acid anhydride hydrolase;
44. pyramidal cell
[large, multipolar, pyramid-shaped, cerebrocortical ganglion cell type which projects axons to other brain areas and the spinal cord. ( CSP )] (UMLS (CSP) C0206441) =Cell ;
=cerebral cortex;
nerve cell;
brain cell;
94. pyrophosphotransferase
[A class of phosphotransferases that catalyzes the transfer of diphosphate-containing groups. EC 2.7.6. ( MSH )] (UMLS (CSP) C0206339) =Amino Acid, Peptide, or Protein; Enzyme
45. Pyramidal Lobe
(UMLS (NCI) C0229584) =Body Part, Organ, or Organ Component
95. Pyroxamide
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called histone deacetylase inhibitors. ( NCI )] (UMLS (NCI) C0966748) Suberoyl-3-aminopyridineamide Hydroxamic Acid =Organic Chemical; Pharmacologic Substance ;
46. pyramidal tract
[nerve fibers which originate in the cerebral cortex, pass through the medullary pyramid, and terminate in the motor brain stem and spinal cord; mediate direct cortical control and initiation of skilled movements. ( CSP )] (UMLS (CSP) C0034229) =Body Part, Organ, or Organ Component ;
=central neural pathway/tract;
96. pyrrole
[5-membered aromatic ring structure with one nitrogen heteroatom. ( CSP )] (UMLS (CSP) C0034325) =Organic Chemical ;
=Heterocyclic Compounds, 1-Ring;
nitrogenous heterocyclic compound =azole;
indole;
phthalimide;
PHYSOSTIGMINE;
carbazole;
tetrapyrrole;
(betaR,deltaR)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid;
TOLMETIN;
(betaR,deltaR)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid
47. pyran
[heterocyclic ring structure containing five carbons and one oxygen that forms the basis of the pyranoses. ( CSP )] (UMLS (CSP) C0034234) =Organic Chemical ;
=Heterocyclic Compounds, 1-Ring;
oxygenous heterocyclic compound =pyrone
97. pyrrolidine
[saturated 5-membered ring structure with one nitrogen heteroatom. ( CSP )] (UMLS (CSP) C0072780) =Organic Chemical ;
=nitrogenous heterocyclic compound;
=Pyrrolidinones;
pyrrolidinedione;
48. pyranose
[ ] (UMLS (CSP) C0598898) =Carbohydrate ;
98. pyrrolidinedione
[ ] (UMLS (CSP) C0597335) =Organic Chemical ;
=pyrrolidine;
=maleimide;
succinimide
49. PYRAZINAMIDE
[antibacterial derived from nicotinic acid, used as a tuberculostatic. ( CSP )] (UMLS (NCI) C0034239) =Organic Chemical; Pharmacologic Substance =Pyrazines;
pyrazine;
[AM500] ANTITUBERCULARS;
=amiloride;
PYRAZINAMIDE 300 MG;
PYRAZINAMIDE 500 MG
99. Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide
[The bromide salt form of rocuronium, an intermediate-acting quaternary aminosteroid with muscle relaxant property. Rocuronium bromide competitively binds to the nicotinic receptor at the motor end plate, and antagonizes acetylcholine binding, which results in skeletal muscle relaxation and paralysis. ( NCI )] (UMLS (NCI) C0069632) =Organic Chemical; Pharmacologic Substance =Androstanols;
ROCURONIUM =ROCURONIUM BROMIDE 10 MG/ML;
50. pyrazine
[6-membered aromatic ring structure with 2 para nitrogen heteroatoms. ( CSP )] (UMLS (CSP) C0178819) =Organic Chemical ;
=diazine;
=PYRAZINAMIDE;
100. pyrroline 5 carboxylate reductase
[ ] (UMLS (CSP) C0311667) =Amino Acid, Peptide, or Protein; Enzyme ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM